切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2015, Vol. 02 ›› Issue (02) : 105 -113. doi: 10.3877/cma.j.issn.1674-6899.2015.02.013

所属专题: 文献

研究生园地

质子泵抑制剂与腹腔镜手术治疗胃食管反流病的Meta分析
朱宝宇1, 施春雨1, 冯野1,()   
  1. 1. 130033 长春,吉林大学中日联谊医院胃肠外科
  • 收稿日期:2015-02-14 出版日期:2015-05-15
  • 通信作者: 冯野

Proton pump inhibitors versus laparoscopic antireflux surgery in the treatment of gastroesophageal reflux disease: A meta analysis

Baoyu Zhu1, Chunyu Shi1, Ye Feng1,()   

  1. 1. Gastrointestinal Surgery, Sino-Japanese Friendship Hospital, Jilin University, Changchun 130033, China
  • Received:2015-02-14 Published:2015-05-15
  • Corresponding author: Ye Feng
  • About author:
    Corresponding author: Feng Ye, Email:
引用本文:

朱宝宇, 施春雨, 冯野. 质子泵抑制剂与腹腔镜手术治疗胃食管反流病的Meta分析[J/OL]. 中华胃食管反流病电子杂志, 2015, 02(02): 105-113.

Baoyu Zhu, Chunyu Shi, Ye Feng. Proton pump inhibitors versus laparoscopic antireflux surgery in the treatment of gastroesophageal reflux disease: A meta analysis[J/OL]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2015, 02(02): 105-113.

目的

系统评价质子泵抑制剂与腹腔镜手术治疗胃食管反流病的疗效和经济评价。

方法

本研究通过计算机检索中国期刊全文数据库(1994~2014.12)、万方数据库(1994~2014.12)、Embase数据库(1995~2014.12)、Pubmed数据库(1994~2014.12)、Cochrane对照试验的中心资料库(2005~2014.12)收集质子泵抑制剂与腹腔镜手术治疗胃食管反流病的随机对照试验。采用Cochrane图书馆RevMan 5.3软件进行Meta分析。

结果

总共纳入13篇目的文献,共包括患者3 623例,质子泵抑制剂组(对照组)1 830例,腹腔镜手术组(试验组)1 793例。其中A级评价文献为8篇,B级评价文献为5篇。Meta分析的最终结果显示:腹腔镜手术组治疗胃食管反流病在治疗后不良反应、胃肠道症状评定及生活质量总体幸福指数评估方面与质子泵抑制剂组相比并无统计学差异。合并优势比(OR)分别为5.00(95% CI为0.69~36.09,P=0.11);-0.20(95% CI为-0.65~0.26,P=0.40);0.55(95% CI为-0.09~1.18,P=0.09);对于在经济评价及治疗失败存在统计学差异。OR分别为1.89(95% CI为0.24~3.53,P=0.02);1.61(95% CI为1.06~2.42,P=0.02)。

结论

腹腔镜手术与质子泵抑制剂对于GERD的治疗在治疗后不良反应;胃肠道症状评定量及患者治疗后的生活质量总体幸福指数评估方面上并无统计学差异,即在治疗胃食管反流病面,质子泵抑制剂和腹腔镜手术治疗影响作用效果无异。

Objective

Systematically evaluate for curative effect and economical evaluation of treating gastroes ophageal refulx disease(GERD) by proton pump inhibitors(PPI) and Laparos copic antireflux surgery(LARS).

Methods

Collecting RCT of treating GERD by PPI and LARS via computer retrieval in CNKI(1944 to 2014.12), Wanfang Database(1994 to 2014.12), Embase Database(1995 to 2014.12), Pubmed Database(1994 to 2014.12)and Cochrane Center Database of Controlled Trial(2005 to 2014.12). Carry on Meta-Analysis by software RevMan5.3 of Cochrane Library.

Results

13 purpose literatures are incorporated totally.Including 3 623 cases, PPI group(control group)1830 cases and LARS group(experiment group)1 793 cases.Among which there are 8 literatures of evaluation A-Level and 5 literatures of evaluation B-Level.The final result of Meta-Analysis shows that on the aspect of post treatment untoward effect and Gastrointestinal symptom rating scale and Quality of life general well-being index, there are no statistical differences between LARS group and PPI group when treating GERD.The odds ratios(RO)are 5.00(95% CI is 0.69~36.09, P=0.11)and-0.20(95% CI is 0.65~0.26, P=0.40)and 0.55(95% CI is 0.09~1.18, P=0.09)respectively.While there exist statistical differences on the aspect of Economic Evaluation 1 year and failure after treatment.The ORs are 1.89(95% Cl is 0.24~3.53, P=0.02)and 1.61(95% Cl is 1.06~2.42, P=0.02)respectively.

Conclusion

There is no obviously statistical difference of gastrointestinal symptom rating and untoward effect after treatment and quality of life general well-being index indicates of GERD via LARS and PPI, which means that there is no more advantages of PPI than LARS on treating GRED.The statistical difference appears in economic evaluation and treatment failure.

图1 文献筛选流程图
表1 纳入文献情况
表2 研究的质量评价
图2 胃肠道症状评定量表森林图
图3 生活质量的总体幸福指数森林图
图4 经济评价森林图(1年内)
图5 治疗失败森林图
图6 治疗后不良反应森林图
图7 胃肠道症状评定量表漏斗图
图8 生活质量的总体幸福指数漏斗图
图9 经济评价漏斗图
图10 治疗失败漏斗图
图11 治疗后不良反应状漏斗图
1
Calvet X, Villoria A. Esophageal diseases: gastroesophageal reflux disease and Barrett′s esophagus[J]. Gastroenterol Hepatol, 2012, 35: 26-34.
2
Liu X, Li M, Xu D, et al.Prevalence and clinical importance of gastroesophageal reflux in Chinese patients with systemic sclerosis[J]. Clin Exp Rheumatol, 2012, 30(2 Suppl 71): 60-66.
3
潘国宗,许国铭,郭慧平,等.北京上海胃食管反流症状的流行病学调查[J].中华消化杂志,1999,19(4):223-225.
4
中华医学会消化病学分会胃肠动力学组.胃食管反流病治疗共识意见[J].中华消化杂志,2007,27(10):689.
5
Kahrilas PJ.Esophageal motor disorders in terms of high-resolution esophageal pressure topography[J]Gastroenterol, 2010, 105(5): 981-987.
6
邹磊,蒋绚,赵景涛.食管下括约肌长度测定的临床意义[J].北京医科大学学报,1999,31(1):90-92.
7
孙晓红,柯美云,王智凤,等.膈脚屏障及食管体部清除功能在胃食管反流中的作用[J].中国医学科学院学报,2002,24(3):289-293.
8
Lee J, Anggiansah A, Anggiansah R, et al.Effects of age on the gastroesophageqal junction, Esophageal motility, and reflux disease [J]. Clin Gastroenterol Hepatol, 2007, 5(12): 1392-1398.
9
Simren M, Silny J, Holloway R, et al.Relevance of ineffective oesophageal motility during esophageal acid clearance[J]. Gut, 2003, 52(6): 784-790.
10
Orr WC, Elsenbruch S, Harnish MJ, et al.Proximal migration of esophageal acid perfusions during waking and sleep[J]. Am J Gastroenterol, 2000, 95(1): 37-42.
11
Wu JC.Gastroesophageal reflux disease: an Asian perspective[J]. J Gastroenterol Hepatol, 2008, 23(12): 1785-1793.
12
Devault K, Castell DO, American College of Gastroentroiogy.Update guidelines for the diagnosis and treatment of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2005, 100(1): 190-200.
13
闫斌,刘庆森,黄启阳,等.原发性小肠淋巴管扩张症1例并文献复习[J].胃肠病学和肝病学杂志,2013,22(5):471-472.
14
张玉琴,巴亚斯古楞,任建林.胃食管反流病的危险因素以及相关疾病的研究概况[J].胃肠病学,2012,17(5):307-310.
15
Ang D, Blondeau K, Sifrim D, et al.The spectrum of motor function abnormalities in gastroesophageal reflux disease and Barrett′s esophagus[J]. Digestion, 2009, 79(3): 158-168.
16
邹方明,庄则豪.胃食管反流病发病机制研究进展[J/CD].中华临床医师杂志:电子版,2011,5(23):7035-7037.
17
Jovov B, Que J, Tobey NA, et al.Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2011, 106(6): 1039-1047.
18
Ashktorab H, Entezari O, Nouraie M, et al.Helicobacter pylori Protection Against Reflux Esophagitis[J]. Dig Dis Sci, 2012, 57(11): 2924-2928.
19
Wu JC, Cheung CM, Wong VW, et al.Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis[J]. Clin Gastroenterol Hepatol, 2007, 5(6): 690-695.
20
Rodrigues Jr L, Faria CM, Geocze S, et al.Helicobacter pylorieradication does not influence gastroesophageal reflux disease: aprospective, parallel, randomized, open-label, controlled trial[J]. Arq Gastroenterol, 2012, 49(1): 56-63.
21
Mohammed I, Cherkas LF, Riley SA, et al.Genetic influences in gastro-oesophageal reflux disease: a twin study[J]. Gut, 2003, 52(8): 1085-1089.
22
Cheng HH, Chang CS, Wang HJ, et al.Interleukin-1beta and-10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients[J]. Gastroenterol Hepatol, 2010, 25(8): 1443-1451.
23
房俊,杨晓俊,喻春钊,等.胃食管反流病发病机制研究进展[J].中华普通外科学文献,2013,7(3):217-221.
24
Takenaka R, Matsuno O, Kitajima K, et al.The use of frequency scale for the symptoms of GERD in assessment of gastro-oesophageal reflex symptoms in asthma[J]. Allergol Immunopathol(Madr), 2010, 38(1): 20-24.
25
刘诗.改变生活方式在治疗胃食管反流病的作用[J].临床消化病杂志,2008,20(1):8.
26
杨建,刘梅,何键,等.胃食管反流病研究进展[J].检验医学与临床,2012,9:1752-1754.
27
中华医学会消化病学分会胃肠动力学组.胃食管反流病治疗共识意见(2007年西安)[J].中华消化杂志,2007,27(10):689-690.
28
Garcia Rodriguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK[J]. Gut, 2006, 55(11): 1538-1544.
29
王炘.胃食管反流病与幽门螺杆菌感染的关系探讨[J].胃肠病学和肝病学杂志,2010,19(1):74-77.
30
孙晓红.胃食管反流病的病理生理机制[J].中华内科杂志,2011,50(8):630-632.
31
Lehmann A. Novel treatments of GERD: focus on the lower esophageal sphincter[J]. Eur Rev Med Pharmacol Sci, 2008, 12(suppl 1): 103-105.
32
李军,李严严,张丽娟,等.老年胃食管反流病患者心理健康评估和干预157例[J].世界华人消化杂志,2008,16(15):1685-1687.
33
Awad RA.Medical and surgical management of esophageal and gastric motor dysfunction[J]. Minerva Gastroenterol Dietol, 2012, 58(3): 227-238.
34
Granero Cendón R, Ruiz Hierro C, Garrido Pérez JI, et al.Evaluation of quality of life in patients operated on for gastroesophageal reflux in the pediatric age[J]. Cir Pediatr, 2012, 25(2): 82-86.
35
Lee WJ, Chan CP, Wang BY.Recent advances in laparoscopic surgery[J]. Asian J Endosc Surgery, 2013, 6(1): 1-8.
36
杨云生,令狐恩强,孙刚,等.胃镜下腔内折叠术治疗胃食管反流病[J].中华消化内镜杂志,2002,19(5):265-267.
37
Amarasiri DL, Pathmeswaran A, de Silva HJ, et al.Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study[J]. BMC Pulm Med, 2013, 13(1): 33.
38
Galmiche JP, Hatlebakk J, Attwood S, et al.Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD The LOTUS Randomized Clinical Trial[J]. JAMA, 2011, 305(19): 1969-1977.
39
Anvari M, Allen C, Marshall J, et al.A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease(GERD): 3-year outcomes[J]. Surg Endosc, 2011, 25(8): 2547-2554.
40
Goeree R, Hopkins R, Marshall JK, et al.Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation[J]. Value Health, 2010, 9(4): 263-273.
41
Fiocca R, Mastracci L, Engström C, et al.Long-Term Outcome of Microscopic Esophagitis in Chronic GERD Patients Treated With Esomeprazole or Laparoscopic Antireflux Surgery in the LOTUS Trial[J]. Am J Gastroenterol, 2010, 105(5): 1015-1023.
42
Epstein D, Bojke L, Sculpher MJ.Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study[J]. BMJ, 2009, 338: b2576.
43
Grant AM, Wileman SM, Ramsay CR, et al.Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial[J]. BMJ, 2008, 337: a2664.
44
Attwood SE, Lundell L, Hatlebakk JG, et al.Medical or Surgical Management of GERD Patients with Barrett′s Esophagus: The LOTUS Trial 3-Year Experience[J]. J Gastrointest Surg, 2008, 12(10): 1646-1655.
45
Lundell L, Attwood S, Ell C, et al.Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial[J]. Gut, 2008, 57(9): 1207-1213.
46
Anvari M, Allen C, Marshall J, et al.A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up[J]. Surg Innor, 2006, 13(4): 238-249.
47
Mehta S, Bennett J, Mahon D, et al.Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up[J]. J Gastrointes Surg, 2006, 10(9): 1312-1317.
48
Olberg P, Johannessen R, Johnsen G, et al.Long-term outcome of surgically and medically treated patients with gastroesophageal reflux disease: A matched-pair follow-up study[J]. Seand J Gastroenterol, 2005, 40(10): 264-274.
49
Mahon D, Rhodes M, Decadt B, et al.Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux[J]. Br J Surg, 2005, 92(6): 695-699.
50
Cookson R, Flood C, Koo B, et al.Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease[J]. Br J Surg, 2005, 92(6): 700-706.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[4] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[5] 白浪, 张雪玉, 白铁成, 贺爱军. 腹腔镜近端胃切除术中圆锥形重叠吻合成形术对Siewert Ⅱ型AEG患者胃食管反流、营养状态的影响研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 679-682.
[6] 李海云, 赵敏娴, 申英末, 杨慧琪. 胃底折叠术预防食管裂孔疝术后并发症的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 485-490.
[7] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[8] 任传富, 杨志, 徐恩, 何梓芸, 罗板鑫, 陈新, 夏雪峰. 腹腔镜疝修补术联合胃底折叠术治疗食管裂孔疝合并胃食管反流病40 例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 507-511.
[9] 杜晨阳, 王勇, 段鑫, 柯文杰, 石念, 武英翔, 罗文. 腹腔镜下食管裂孔疝修补术后吞咽困难的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 523-527.
[10] 胡志伟, 吴继敏, 邓昌荣, 战秀岚, 纪涛, 王峰, 田书瑞, 陈冬, 张玉, 刘健男, 宋庆. 抗反流黏膜套扎治疗顽固性胃食管反流病[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 227-233.
[11] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[12] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[13] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[14] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[15] 胡小靖, 张华. 妊娠期卵巢囊肿蒂扭转的诊断与治疗[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 197-201.
阅读次数
全文


摘要